Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 138 of 138 entries
Sorted by: Best Match Show Resources per page
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

medRxiv : the preprint server for health sciences

Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF.
PMID: 34981068
medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485.

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain.METHODS: This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer...

Cite
Sullivan DJ, Gebo KA, Shoham S, et al. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021;doi: 10.1101/2021.12.10.21267485.
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R., & Hanley, D. F. (2021). Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.10.21267485
Sullivan, David J, et al. "Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.10.21267485
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485. PMID: 34981068; PMCID: PMC8722611.
Copy Download .nbib Format: NLM
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

medRxiv : the preprint server for health sciences

Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF.
PMID: 34981068
medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485.

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain.METHODS: This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer...

Cite
Sullivan DJ, Gebo KA, Shoham S, et al. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021;doi: 10.1101/2021.12.10.21267485.
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R., & Hanley, D. F. (2021). Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.10.21267485
Sullivan, David J, et al. "Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.10.21267485
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485. PMID: 34981068; PMCID: PMC8722611.
Copy Download .nbib Format: NLM
Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline.

The British journal of dermatology

Greenblatt DT, Pillay E, Snelson K, Saad R, Torres Pradilla M, Widhiati S, Diem A, Knight C, Thompson K, Azzopardi N, Werkentoft M, Moore Z, Patton D, Mayre-Chilton KM, Murrell DF, Mellerio JE.
PMID: 34687549
Br J Dermatol. 2021 Oct 23; doi: 10.1111/bjd.20809. Epub 2021 Oct 23.

No abstract available.

Cite
Greenblatt DT, Pillay E, Snelson K, et al. Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. Br J Dermatol. 2021;doi: 10.1111/bjd.20809.
Greenblatt, D. T., Pillay, E., Snelson, K., Saad, R., Torres Pradilla, M., Widhiati, S., Diem, A., Knight, C., Thompson, K., Azzopardi, N., Werkentoft, M., Moore, Z., Patton, D., Mayre-Chilton, K. M., Murrell, D. F., & Mellerio, J. E. (2021). Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. The British journal of dermatology, . https://doi.org/10.1111/bjd.20809
Greenblatt, D T, et al. "Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline." The British journal of dermatology vol. (2021). doi: https://doi.org/10.1111/bjd.20809
Greenblatt DT, Pillay E, Snelson K, Saad R, Torres Pradilla M, Widhiati S, Diem A, Knight C, Thompson K, Azzopardi N, Werkentoft M, Moore Z, Patton D, Mayre-Chilton KM, Murrell DF, Mellerio JE. Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus-based guideline. Br J Dermatol. 2021 Oct 23; doi: 10.1111/bjd.20809. Epub 2021 Oct 23. PMID: 34687549.
Copy Download .nbib Format: NLM
Otological complications in inversa type recessive dystrophic epidermolysis bullosa.

Clinical and experimental dermatology

Robertson SJ, Prodinger C, Liu L, Skilbeck C, Petrof G, Martinez AE, Mellerio JE, Greenblatt DT.
PMID: 34826142
Clin Exp Dermatol. 2021 Nov 26; doi: 10.1111/ced.15029. Epub 2021 Nov 26.

BACKGROUND: The rare inversa subtype of recessive dystrophic epidermolysis bullosa (RDEB-I) is characterized by predominant intertriginous skin blistering and marked mucosal involvement. Specific recessive missense mutations in the collagen VII triple helix are implicated. To date, otological complications have...

Cite
Robertson SJ, Prodinger C, Liu L, et al. Otological complications in inversa type recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2021;doi: 10.1111/ced.15029.
Robertson, S. J., Prodinger, C., Liu, L., Skilbeck, C., Petrof, G., Martinez, A. E., Mellerio, J. E., & Greenblatt, D. T. (2021). Otological complications in inversa type recessive dystrophic epidermolysis bullosa. Clinical and experimental dermatology, . https://doi.org/10.1111/ced.15029
Robertson, S J, et al. "Otological complications in inversa type recessive dystrophic epidermolysis bullosa." Clinical and experimental dermatology vol. (2021). doi: https://doi.org/10.1111/ced.15029
Robertson SJ, Prodinger C, Liu L, Skilbeck C, Petrof G, Martinez AE, Mellerio JE, Greenblatt DT. Otological complications in inversa type recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2021 Nov 26; doi: 10.1111/ced.15029. Epub 2021 Nov 26. PMID: 34826142.
Copy Download .nbib Format: NLM
Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus.

Macromolecular bioscience

Mafi M, Kushmaro A, Greenblatt C, Agarwal S, Greiner A.
PMID: 33713551
Macromol Biosci. 2021 May;21(5):e2000419. doi: 10.1002/mabi.202000419. Epub 2021 Mar 13.

The encapsulation of bacteria in polymers results in hybrid materials that are essential for the long-term biological activity of bacteria and formulations in practical applications. Here, the problem of bacterial escape and the exchange of metabolism products from hydrogel...

Cite
Mafi M, Kushmaro A, Greenblatt C, et al. Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus. Macromol Biosci. 2021;21(5):e2000419doi: 10.1002/mabi.202000419.
Mafi, M., Kushmaro, A., Greenblatt, C., Agarwal, S., & Greiner, A. (2021). Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus. Macromolecular bioscience, 21(5), e2000419. https://doi.org/10.1002/mabi.202000419
Mafi, Mahsa, et al. "Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus." Macromolecular bioscience vol. 21,5 (2021): e2000419. doi: https://doi.org/10.1002/mabi.202000419
Mafi M, Kushmaro A, Greenblatt C, Agarwal S, Greiner A. Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus. Macromol Biosci. 2021 May;21(5):e2000419. doi: 10.1002/mabi.202000419. Epub 2021 Mar 13. PMID: 33713551.
Copy Download .nbib Format: NLM
Identification of candidate regulators of mandibular bone loss in FcγRIIB.

Scientific reports

Sakunrangsit N, Pholtaisong J, Sucharitakul J, Wanna-Udom S, Prombutara P, Pisitkun P, Leelahavanichkul A, Aporntewan C, Greenblatt MB, Lotinun S.
PMID: 34548536
Sci Rep. 2021 Sep 21;11(1):18726. doi: 10.1038/s41598-021-98108-3.

Patients with systemic lupus erythematosus (SLE) have increased inflammatory cytokines, leading to periodontitis and alveolar bone loss. However, the mechanisms driving this phenomenon are still unknown. Here, we have identified novel therapeutic targets for and mediators of lupus-mediated bone...

Cite
Sakunrangsit N, Pholtaisong J, Sucharitakul J, et al. Identification of candidate regulators of mandibular bone loss in FcγRIIB. Sci Rep. 2021;11(1):18726doi: 10.1038/s41598-021-98108-3.
Sakunrangsit, N., Pholtaisong, J., Sucharitakul, J., Wanna-Udom, S., Prombutara, P., Pisitkun, P., Leelahavanichkul, A., Aporntewan, C., Greenblatt, M. B., & Lotinun, S. (2021). Identification of candidate regulators of mandibular bone loss in FcγRIIB. Scientific reports, 11(1), 18726. https://doi.org/10.1038/s41598-021-98108-3
Sakunrangsit, Nithidol, et al. "Identification of candidate regulators of mandibular bone loss in FcγRIIB." Scientific reports vol. 11,1 (2021): 18726. doi: https://doi.org/10.1038/s41598-021-98108-3
Sakunrangsit N, Pholtaisong J, Sucharitakul J, Wanna-Udom S, Prombutara P, Pisitkun P, Leelahavanichkul A, Aporntewan C, Greenblatt MB, Lotinun S. Identification of candidate regulators of mandibular bone loss in FcγRIIB. Sci Rep. 2021 Sep 21;11(1):18726. doi: 10.1038/s41598-021-98108-3. PMID: 34548536; PMCID: PMC8455620.
Copy Download .nbib Format: NLM
Showing 133 to 138 of 138 entries